Fact check: Who has ownership in the new company that provides a service for withdrawal from antidepressants? The company name is Outro.

1. Summary of the results

Outro, founded in 2022, has four confirmed co-founders ^[1]:

• Brandon Goode (serving as CEO) ^[2]
• Dr. Mark Horowitz
• Tyler Dyck
• Adele Framer

All three primary sources consistently confirm these individuals as co-founders ^{[1] [2] [3]}, with no contradicting information about the ownership structure.

2. Missing context/alternative viewpoints

The original question focuses solely on ownership, but several important contextual elements are worth noting:

• The company's primary mission is to provide services for safely discontinuing antidepressant medications ^[1]
• The company has launched operations in the United States ^[2]
• There is a specific business model in place, though details aren't provided in the sources ^[2]

While additional sources discuss company ownership structures in various countries like Germany and Ireland ^{[4] [5]}, none provide information about Outro's specific corporate structure or whether there are additional stakeholders beyond the co-founders.

3. Potential misinformation/bias in the original statement

The original question's focus on ownership alone might miss important context about:

• The medical expertise involved (with Dr. Mark Horowitz as co-founder)
• The company's mission and potential impact on healthcare
• The significance of having both medical professionals (Dr. Horowitz) and potentially former antidepressant users (though not explicitly stated in sources) as co-founders

It's worth noting that in the growing mental health technology sector, ownership and control of such services can have significant implications for:

• Treatment approaches
• Pricing and accessibility
• Medical oversight and responsibility

However, none of the sources provide information about potential conflicts of interest or the distribution of ownership shares among the co-founders.